SEPN Long Put Strategy
SEPN (Septerna, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products candidates for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. The company develops SEP-786, an oral small molecule PTH1R agonist for hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 NAM for chronic spontaneous urticaria and other mast cell diseases; TSHR Program, an oral small molecule TSHR NAM for Graves' disease and thyroid eye disease. It also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders including obesity and type 2 diabetes. Septerna, Inc. was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. The company was incorporated in 2019 and is headquartered in South San Francisco, California.
SEPN (Septerna, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.12B, a beta of 2.20 versus the broader market, a 52-week range of 8.86-32.63, average daily share volume of 319K, a public-listing history dating back to 2024, approximately 75 full-time employees. These structural characteristics shape how SEPN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.20 indicates SEPN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long put on SEPN?
A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration.
Current SEPN snapshot
As of May 15, 2026, spot at $27.27, ATM IV 64.80%, IV rank 7.57%, expected move 18.58%. The long put on SEPN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this long put structure on SEPN specifically: SEPN IV at 64.80% is on the cheap side of its 1-year range, which favors premium-buying structures like a SEPN long put, with a market-implied 1-standard-deviation move of approximately 18.58% (roughly $5.07 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SEPN expiries trade a higher absolute premium for lower per-day decay. Position sizing on SEPN should anchor to the underlying notional of $27.27 per share and to the trader's directional view on SEPN stock.
SEPN long put setup
The SEPN long put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SEPN near $27.27, the first option leg uses a $27.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SEPN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SEPN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Put | $27.00 | $1.93 |
SEPN long put risk and reward
- Net Premium / Debit
- -$192.50
- Max Profit (per contract)
- $2,506.50
- Max Loss (per contract)
- -$192.50
- Breakeven(s)
- $25.08
- Risk / Reward Ratio
- 13.021
Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium.
SEPN long put payoff curve
Modeled P&L at expiration across a range of underlying prices for the long put on SEPN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$2,506.50 |
| $6.04 | -77.9% | +$1,903.66 |
| $12.07 | -55.8% | +$1,300.81 |
| $18.10 | -33.6% | +$697.97 |
| $24.12 | -11.5% | +$95.12 |
| $30.15 | +10.6% | -$192.50 |
| $36.18 | +32.7% | -$192.50 |
| $42.21 | +54.8% | -$192.50 |
| $48.24 | +76.9% | -$192.50 |
| $54.27 | +99.0% | -$192.50 |
When traders use long put on SEPN
Long puts on SEPN hedge an existing long SEPN stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying SEPN exposure being hedged.
SEPN thesis for this long put
The market-implied 1-standard-deviation range for SEPN extends from approximately $22.20 on the downside to $32.34 on the upside. A SEPN long put expresses a directional view that the underlying closes below the strike minus premium at expiration, frequently sized to hedge an existing long SEPN position with one put per 100 shares held. Current SEPN IV rank near 7.57% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SEPN at 64.80%. As a Healthcare name, SEPN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SEPN-specific events.
SEPN long put positions are structurally bearish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SEPN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SEPN alongside the broader basket even when SEPN-specific fundamentals are unchanged. Long-premium structures like a long put on SEPN are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current SEPN chain quotes before placing a trade.
Frequently asked questions
- What is a long put on SEPN?
- A long put on SEPN is the long put strategy applied to SEPN (stock). The strategy is structurally bearish: A long put buys downside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes below the strike minus premium at expiration. With SEPN stock trading near $27.27, the strikes shown on this page are snapped to the nearest listed SEPN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SEPN long put max profit and max loss calculated?
- Max profit equals the strike minus premium times 100 (reached at zero); max loss equals the premium times 100. Breakeven is strike minus premium. For the SEPN long put priced from the end-of-day chain at a 30-day expiry (ATM IV 64.80%), the computed maximum profit is $2,506.50 per contract and the computed maximum loss is -$192.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SEPN long put?
- The breakeven for the SEPN long put priced on this page is roughly $25.08 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SEPN market-implied 1-standard-deviation expected move is approximately 18.58%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long put on SEPN?
- Long puts on SEPN hedge an existing long SEPN stock position or express a bearish view with defined risk; position sizing typically scales the put notional to the underlying SEPN exposure being hedged.
- How does current SEPN implied volatility affect this long put?
- SEPN ATM IV is at 64.80% with IV rank near 7.57%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.